Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank93
3Y CAGR+26.9%
5Y CAGR+152.5%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+26.9%/yr
Annual compound
5Y CAGR
+152.5%/yr
Recent deceleration
Percentile
P93
Near historical high
vs 5Y Ago
102.7x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.28 | +145.2% |
| 2024 | 0.11 | -37.3% |
| 2023 | 0.18 | +33.0% |
| 2022 | 0.14 | +4619.1% |
| 2021 | 0.00 | +6.5% |
| 2020 | 0.00 | +79.1% |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |